News

David Siegel, M.D., talks about the TOURMALINE-MM3 study and the treatment of multiple myeloma

David Siegel, M.D., hematologist/oncologist, Hackensack University Medical Center, John Theurer Cancer Center, talks about how the outcomes of the TOURMALINE-MM3 study will or will not change how multiple myeloma patients are treated, who have had at least one prior therapy.

READ FULL ARTICLE ON OBRONCOLOGY.COM